New to hormones? Start here for clear, practical answers →

Non-Binary and Low-Dose HRT

Most hormone services have a standard plan built around a full change in one direction. Some people want some of the changes and not others, some want to go slowly and see how it feels, and some want a body that is not read clearly either way. Low-dose HRT, sometimes called microdosing, is how many of them approach it.

The short version: a lower dose generally means slower and often smaller changes, not a choice of which changes you get. A fair number of the non-binary patients I coordinate for surgery started low, changed the dose along the way, or stopped once they had what they wanted, and knowing this up front helped them plan well.

On this page
  1. What "low dose" and "microdosing" mean
  2. What a lower dose actually does
  3. Stopping once you have what you want
  4. The bone health question
  5. Practical differences at a low dose
  6. What the evidence covers
  7. Talking to a prescriber
  8. FAQ

What "low dose" and "microdosing" mean

"Low dose" usually means a dose below the standard starting or target dose for someone aiming at a full binary change, and a lower target for blood levels. There is no single figure; it is whatever you and a prescriber agree.

"Microdosing" is an informal term from community spaces, not a medical one. People use it for anything from a slightly reduced dose to a very small one, so two people who say they are microdosing may be taking very different amounts. If you use the word with a prescriber, say what you actually mean by it.

Some people also use a low dose as a starting point, to see how they feel before deciding whether to go further.

What a lower dose actually does

Hormones work on the same body systems whatever the dose. A lower dose tends to mean changes arrive more slowly and may stop at a smaller point, but the same kinds of changes happen, broadly in the same order. You cannot, for example, take a low dose of testosterone and get facial hair without any voice change, or a low dose of estrogen and get softer skin without any breast growth.

Some changes are sensitive to small amounts. On testosterone, voice deepening and clitoral growth can begin at low doses, and both are permanent. On estrogen, breast development begins early and is permanent once established. If there is a change you definitely do not want, have that conversation with a prescriber before starting, not after.

Other changes, such as fat redistribution, skin texture, body hair and muscle, tend to be slower and more dose-dependent, and more likely to reverse if you stop. What changes, and when and the masculinizing timeline set out which is which. Is HRT reversible? goes into it further.

Before you start

Write down the two or three changes you most want and the one or two you most want to avoid, and take the list to your first appointment. It makes the conversation specific, and a prescriber can tell you straight whether a lower dose will get you there.

Stopping once you have what you want

Some people take a standard or low dose until they reach the changes they want, then stop or reduce. The permanent changes stay: a voice that has dropped or breast tissue that has grown. The reversible ones tend to drift back over the following months as your own hormones take over again. Is HRT reversible? sets out which is which.

Stopping or reducing is something to plan with a prescriber, not alone. It affects periods, mood, energy and bone health, and a prescriber can plan it so it is not a shock.

The bone health question

Your bones need a reasonable level of some sex hormone, estrogen or testosterone, to stay strong. That matters most for people who have had their gonads removed or are taking something that suppresses their own hormones, such as a GnRH agonist or a strong anti-androgen, without replacing them fully.

If your plan lowers your own hormones and only partly replaces them, ask your prescriber how they will keep an eye on bone health. Long-term health covers it in more detail.

Practical differences at a low dose

On testosterone, periods may carry on. A standard dose stops periods for most people within the first several months; a low dose may not, or may make them irregular rather than stopping them. If stopping periods is one of your goals, say so, because it may push the dose up or call for a separate medicine. Periods on testosterone covers the options.

Low-dose testosterone is not contraception. Neither is a standard dose, and at a low dose there is even less reason to assume ovulation has stopped. If pregnancy is possible from the sex you have, you still need contraception, and the periods page covers which kinds work alongside testosterone.

On the feminizing side, estrogen alone may do little. A low dose of estrogen without an anti-androgen can leave testosterone high enough that changes are slight or uneven. Some people want exactly that; others are surprised by it. Estrogen on its own, called monotherapy, works for some people at standard doses, but at a low dose it is worth asking what your testosterone level is likely to be. Anti-androgens explains the options if you want testosterone lowered only partly.

Blood results are harder to read. Labs flag results against typical male or female reference ranges, and a deliberately in-between plan will often sit outside both. That is not necessarily a problem, but it means you and your prescriber should agree the target in advance, rather than reacting to what the lab sheet flags. Reading your blood results explains the flags.

What the evidence covers

Almost all research on gender-affirming hormones has looked at standard doses aiming at a binary change. Low-dose and non-binary regimens have been studied far less, so nobody can give you a reliable table of what a given low dose will do over a given time. Prescribers are working from general knowledge of how the hormones behave, and from their own patients.

That does not make it unsafe or unwise. It means expectations should be loose, blood tests still matter, and the plan will probably be adjusted along the way. The WPATH Standards of Care, version 8, recognise non-binary people's goals and support individualised treatment, but they do not set out specific low-dose regimens.

Talking to a prescriber

Some prescribers are comfortable with non-binary goals and will build a plan around them. Others default to the standard regimen and need a clear explanation. Either way, describing what you want in terms of changes, rather than a label, gets a better answer.

Useful questions to ask:

  • Which of the changes I want are likely at a lower dose, and roughly how slowly?
  • Which changes I do not want are still likely, and are they permanent?
  • What blood levels are you aiming for, and how often will you check them?
  • If I want to stop or reduce later, how would we do it?

Monitoring is the same as on a standard dose. Informed consent services tend to be the most flexible about non-standard plans, and blood tests and monitoring explains what gets checked.

If a prescriber insists on the standard dose

Ask them to explain the medical reason. Sometimes there is one, often bone health if your own hormones are being suppressed. If the reason is only that it is their usual plan, it is reasonable to look for a prescriber who works with non-binary patients.

Frequently asked questions

What is microdosing HRT?

An informal term for taking hormones at a lower dose than the standard, with no fixed definition. Say what dose you actually mean when you talk to a prescriber. See what low dose and microdosing mean.

Can I choose which changes I get from hormones?

Not really. A lower dose slows changes and may make them smaller, but you get the same kinds of change, and some sensitive ones, such as voice deepening on testosterone, can start at low doses. See what a lower dose actually does.

Can I stop once I have the changes I want?

Some people do. Permanent changes stay, and reversible ones tend to drift back. Plan it with a prescriber. See stopping once you have what you want.

Is low-dose HRT safe?

It has been studied much less than standard doses, so expectations should be loose and monitoring still matters, including for bone health. See what the evidence covers and the bone health question.